Clearer questions. More informed care.Our commercial disclosure

Brand alternatives

Best MEDVi alternatives: a closer comparison

Compare read the fda letter before relying on marketing assurances across selected providers, with sources and a disclosed CoreAge Rx placement.

Document research · No independent medical review claimed
On this page
  1. How to use this comparison
  2. 01. CoreAge Rx — commercial first position
  3. 02. Ro
  4. 03. Mochi Health
  5. 04. Henry Meds
  6. 05. Embody
  7. 06. Remedy Meds
  8. 07. Hims
  9. 08. Eden
  10. 09. MEDVi
  11. Make the comparison specific to you
  12. Sources & research notes

This guide looks at read the fda letter before relying on marketing assurances. The aim is to help you ask a better next question, whether you are checking a first prescription offer or thinking about moving to another service.

The services below have different care and payment models. We describe their own published terms and link to fuller files, so an appealing price can be read alongside the work, obligations, and uncertainties attached to it.

How to use this comparison

For someone comparing MEDVi, begin with this issue: read the fda letter before relying on marketing assurances. Different arrangements can make more sense for different needs, so ask the same concrete question of every candidate.

CoreAge Rx has a commercial first position in this guide. We may be compensated through its links. The sequence is not an independently calculated medical ranking, and inclusion does not mean every service supplies every feature discussed here.

Use the documents for the actual treatment, location, and payment agreement. A service may be useful to compare even when its approach differs: a consultation-only pathway, an inclusive package, and a care membership should not be assumed to buy the same thing.

  • Name the exact care service.
  • Request the complete payment schedule.
  • Check the product, pharmacy, and exit terms.
Source notes1

01. CoreAge Rx — commercial first position

This is the featured commercial partner. The placement should not be interpreted as proof of superior outcomes, lower total cost, or the best clinical choice for a particular person.

CoreAge Rx describes assessment online followed by dispensing when a clinician issues a prescription. It is Panda Bear’s commercial partner; that arrangement determines its featured position, not an assessment of treatment quality.

Its offer advertises semaglutide from $99 and tirzepatide from $149. The billing help uses $447 paid for three months to illustrate a $149 monthly equivalent. No additional membership fee is advertised, but the selected product and supply period still control the invoice.

Will my receipt show one payment or recurring charges, and which pharmacy will be on the label?

Open our CoreAge Rx review for the terms, evidence limits, and published contact routes.

Source notes23456

02. Ro

Ro’s Body pathway describes branded medication access and help with insurance. Membership, prescribing review, and the pharmacy benefit remain distinct parts of the arrangement.

The membership offer shows $39 initially, then $149 monthly. An annual payment can produce a $74 monthly equivalent. None of those membership amounts includes the medicine itself; insurance or the cash-pay pharmacy price must be added.

If insurance refuses the medicine, what will I already have paid for care and what options remain?

Open our Ro review for the terms, evidence limits, and published contact routes.

Source notes78

03. Mochi Health

Mochi’s membership provides the care arrangement; its medication bill is additional. An August 2026 explanation describes medication prices that vary by tier, so older flat-price descriptions need checking.

The standard membership is $79 monthly, with a $39 introductory month advertised. Published medication ranges are $60–$99 for semaglutide and $90–$199 for tirzepatide. These ranges are not instructions to choose a dose according to price.

What is the recurring total at the tier my clinician prescribes, and on which dates are the two charges taken?

Open our Mochi Health review for the terms, evidence limits, and published contact routes.

Source notes91011

04. Henry Meds

Henry Meds offers several weight-management arrangements with remote assessment. Its FAQ describes care, supplies, and prescribed medicine within packages, including different formulations and treatment durations.

GLP-1 programs are advertised from $179 monthly. The selected route and agreement matter: an oral compound, an injection, and a longer purchase should each be quoted explicitly rather than grouped under that starting number.

What would remain owed if treatment stopped halfway through the agreement, and which exception rules could apply?

Open our Henry Meds review for the terms, evidence limits, and published contact routes.

Source notes12

05. Embody

Embody publishes contact details, privacy information, and a pharmacy-partner list. Its legal documents are more useful for checking who operates the service than similarities between brand names.

A complete current invoice covering every treatment was not established. Ask for medicine, care access, supplies, shipping, duration, and renewal as individual items so the quoted package can be compared fairly.

Which legal business is on my agreement, and who separately provides medical care and dispensing?

Open our Embody review for the terms, evidence limits, and published contact routes.

Source notes131415

06. Remedy Meds

Remedy Meds offers remote weight-management services and publishes a support number in its help material. Determine whether the selected program includes components beyond medicine and clinical care.

We could not establish one current medication-inclusive rate across all offers. Request separate amounts for medication, clinical access, any meal program, and each planned shipment, followed by the normal renewal figure.

Which purchases qualify for the warranty, and how do I stop ordinary renewals without making a warranty claim?

Open our Remedy Meds review for the terms, evidence limits, and published contact routes.

Source notes1617

07. Hims

Hims & Hers announced a revised weight-loss approach in March 2026 emphasizing approved products while describing limited clinically indicated compounding. That announcement does not promise a particular prescription to every applicant.

Its materials distinguish a Weight Loss Membership from a Medication Plan. We did not establish a single combined rate covering every current pathway. A historical semaglutide promotion may describe a different offer.

Which current product, membership clause, and medication cancellation clause would govern my enrollment?

Open our Hims review for the terms, evidence limits, and published contact routes.

Source notes1819

08. Eden

Eden presents personalized weight care and directs members to its patient system. To understand the purchase, identify the care membership separately from the pharmacy transaction, even if enrollment presents them together.

A $99 compounded-semaglutide starting offer carries a membership qualification. The accessible homepage does not establish a universal combined total. Ask for both components, the length of the offer, and the later refill amount.

What does the membership add to the drug price, and what evidence concerns the exact formulation being proposed?

Open our Eden review for the terms, evidence limits, and published contact routes.

Source notes2021

09. MEDVi

An FDA warning letter dated February 20, 2026 addresses MEDVi’s marketing of unapproved GLP-1 drugs. It is relevant evidence about the claims specified there. The existence of a website, support team, or clinical intake does not settle those concerns.

The reviewed documents do not establish a dependable single price for all MEDVi weight-management plans. QUAD pricing belongs to another treatment category and cannot be used to budget for a GLP-1 prescription.

What product would I receive, and where can I read the current response to the specific FDA concerns?

Open our MEDVi review for the terms, evidence limits, and published contact routes.

Source notes222324

Make the comparison specific to you

After reading the options, select the questions you still need answered. Ask each provider for the same time period, named prescription, and clinical access. Record unclear items as unresolved instead of choosing the lowest advertised number.

If the medicine, route, or treatment goal differs, discuss that difference with the clinician before treating it as an ordinary shopping substitution. The cost worksheet can help compare payments while keeping the medical decision separate.

Source notes25

Trace the information

Sources & research notes

Provider documents describe the provider’s own offer. Official medical references explain context; they do not endorse this publication or its featured partner.

  1. FDA: concerns with unapproved GLP-1 drugs Regulatory / public agency · Checked September 22, 2026
  2. CoreAge Rx: official treatment overview Provider-published information · Checked September 22, 2026
  3. CoreAge Rx: current sale offer Provider-published information · Checked September 22, 2026
  4. CoreAge Rx: plan billing explained Provider-published information · Checked September 22, 2026
  5. CoreAge Rx: contact and professional-entity disclosures Provider-published information · Checked September 22, 2026
  6. CoreAge Rx: purchasing process Provider-published information · Checked September 22, 2026
  7. Weight Loss - Ro Body Membership | Ro Provider-published information · Checked September 22, 2026
  8. Ro - Telehealth for ED, Hair loss, Skincare, Fertility and More Provider-published information · Checked September 22, 2026
  9. Online Medical Weight Loss Program | Mochi Health Provider-published information · Checked September 22, 2026
  10. Mochi: August 2026 dose-based pricing Provider-published information · Checked September 22, 2026
  11. Contact us | Mochi Health Provider-published information · Checked September 22, 2026
  12. GLP-1 Weight Loss Treatment | Henry Provider-published information · Checked September 22, 2026
  13. Embody | Personalized GLP-1 Weight Loss Care Provider-published information · Checked September 22, 2026
  14. Embody: corporate identity in privacy policy Provider-published information · Checked September 22, 2026
  15. Contact Embody – Customer Service Provider-published information · Checked September 22, 2026
  16. RemedyMeds Provider-published information · Checked September 22, 2026
  17. Remedy Meds: official phone support Provider-published information · Checked September 22, 2026The latest direct refresh was unreadable. The earlier source date is retained; obtain the current document before relying on commercial terms.
  18. Hims & Hers: March 9, 2026 weight-loss strategy announcement Provider-published information · Checked September 22, 2026
  19. Hims: terms updated August 31, 2026 Provider-published information · Checked September 22, 2026The alternate retrieval returned a version dated April 23, 2026; the retained earlier capture is dated August 31, 2026. We have not reconciled these versions. Confirm the agreement shown at your actual checkout before relying on a cancellation deadline.
  20. Fast, Personal Prescription Health & Wellness | Eden Provider-published information · Checked September 22, 2026
  21. Contact Us | Eden Provider-published information · Checked September 22, 2026
  22. MEDVi: provider, pharmacy, and contact disclosures Provider-published information · Checked September 22, 2026
  23. FDA: MEDVi warning letter, February 20, 2026 Regulatory / public agency · Checked September 22, 2026
  24. MEDVi QUAD: product and ingredient page Provider-published information · Checked September 22, 2026
  25. FDA: risks of compounded drugs Regulatory / public agency · Checked September 22, 2026

Use this guide to prepare questions, not to choose or change a prescription without clinical advice. Research method · Commercial disclosure

Your next useful question

Keep the conversation going.